Nanofitins targeting heat shock protein 110: An innovative immunotherapeutic modality in cancer.
Marcion G, Hermetet F, Neiers F, Uyanik B, Dondaine L, Dias AMM, Da Costa L, Moreau M, Bellaye PS, Collin B, Gobbo J, Briand L, Seigneuric R, Kitten O, Cinier M, Garrido C.
Marcion G, et al. Among authors: collin b.
Int J Cancer. 2021 Jun 15;148(12):3019-3031. doi: 10.1002/ijc.33485. Epub 2021 Mar 4.
Int J Cancer. 2021.
PMID: 33506516